GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ocata Therapeutics Inc. (OCAT) [hlAlert]

Rating:
Buy ACTC
down 39.51 %

Advanced Cell Technology, Inc. (ACTC) rated Buy with price target $0.45 by Maxim Group

Posted on: Tuesday,  Sep 10, 2013  8:25 AM ET by Maxim Group

Maxim Group rated Buy Ocata Therapeutics Inc. (NASDAQ: OCAT) on 09/10/2013, when the stock price was $6.58. Since
then, Ocata Therapeutics Inc. has lost 39.51% as of 01/20/2016's recent price of $3.98.
If you would have followed this Maxim Group's recommendation on OCAT, you would have lost 39.51% of your investment in 862 days.

Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintains a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research. The Company?s emerging field of treatment called regenerative medicine or cell therapy refers to treatments that are founded on the concept of producing new cells to replace malfunctioning or damaged cells as a vehicle to treat disease and injury. It focuses on the development of effective methods to generate replacement cells from both human embryonic and adult stem cells.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2013 8:25 AM Buy
None
6.58 45.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy